| 1 |
Qiang W, Xiao C, Li Z, et al. Impactful publications of critical care medicine research in China: a bibliometric analysis [J]. Front Med (Lausanne), 2022, 9: 974025.
|
| 2 |
邓星奇, 沈侃. 重症医学在我国的发展历程 [J]. 医学综述, 2021, 27(22): 4369-4373.
|
| 3 |
Li R, Rivers C, Tan Q, et al. Estimated demand for US hospital inpatient and intensive care unit beds for patients with COVID-19 based on comparisons with Wuhan and Guangzhou, China [J]. JAMA Netw Open, 2020, 3(5): e208297.
|
| 4 |
詹洪春, 王霞, 潘锋. 提升重症医学服务能力是健康中国建设的重要内容 [J]. 中国当代医药, 2024, 31(24): 1-3.
|
| 5 |
Cani E, Tsang JLY, Binnie A, et al. Barriers to participation in biosampling-based translational research: a cross-sectional survey of Canadian critical care researchers [J]. PLoS One, 2024, 19(5): e0303304.
|
| 6 |
Charalampous T, Alcolea-Medina A, Snell LB, et al. Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units [J]. Genome Med, 2021, 13(1): 182.
|
| 7 |
Hu L, Li D, Liu H, et al. Enhancing fairness in AI-enabled medical systems with the attribute neutral framework [J]. Nat Commun, 2024, 15(1): 8767.
|
| 8 |
Dumas G, Arabi YM, Bartz R, et al. Diagnosis and management of autoimmune diseases in the ICU [J]. Intens Care Med, 2024, 50(1): 17-35.
|
| 9 |
Kuklin V, Sovershaev M, Bjerner J, et al. Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis [J]. Crit Care, 2024, 28: 12.
|
| 10 |
Odetola FO, Lin P, Ye W, et al. Health care resource use and costs after hospitalization with multiple organ dysfunction in children [J]. JAMA Netw Open, 2025, 8(1): e2456246.
|
| 11 |
Srdić T, Đurašević S, Lakić I, et al. From molecular mechanisms to clinical therapy: understanding sepsis-induced multiple organ dysfunction [J]. Int J Mol Sci, 2024, 25(14): 7770.
|
| 12 |
van Amstel RBE, Bartek B, Vlaar APJ, et al. Temporal transitions of the hyperinflammatory and hypoinflammatory phenotypes in critical illness [J]. Am J Respir Crit Care Med, 2025, 211(3): 347-356.
|
| 13 |
程青虹, 柳建萍. 以转化医学理念指导重症医学研究生的培养 [J]. 农垦医学, 2019, 41(3): 276-277.
|
| 14 |
Guinovart JJ, Arimon M. Scientists in education: a biomedical research institute's perspective [J]. Biochem Mol Biol Educ, 2020, 48(6): 559-562.
|
| 15 |
张文珊, 钱轶峰, 汪雪玲, 等. 省部级科研平台资源配置效能影响因素以及科研投入要素的阈值效应——以上海市医学领域重点实验室为例 [J]. 科技管理研究, 2023, 43(20): 100-106.
|
| 16 |
袁雪燕, 刘玲, 邱海波. 2023急性呼吸窘迫综合征全球新标准: 进步与局限 [J]. 中华医学杂志, 2024, 104(15): 1216-1220.
|
| 17 |
师亚敏, 潘勋. 公共科研平台技术队伍建设与人员管理的实践与思考 [J]. 实验技术与管理, 2015, 32(9): 233-235.
|
| 18 |
刘付蓉, 翁利, 杜斌. 2020年至2022年中国重症医学临床研究进展 [J/OL]. 中华重症医学电子杂志, 2024, 10(1): 48-53.
|
| 19 |
于凯江. 中国重症医学的未来发展 [J/OL]. 中华重症医学电子杂志, 2016, 2(3): 152-155.
|
| 20 |
王妍, 李雪珠, 黄力维, 等. 重症医学领域2023年SCI论文研究热点的可视化分析 [J/OL]. 中华重症医学电子杂志, 2024, 10(3): 218-226.
|
| 21 |
戴娇. 中医与现代医学在ICU疾病管理中的协同作用 [J]. 中医药管理杂志, 2024, 32(2): 90-92.
|